Advertisement

Topics

Hemophilia Federation of America Company Profile

11:35 EST 22nd November 2017 | BioPortfolio


News Articles [403 Associated News Articles listed on BioPortfolio]

Hundreds Gather at National AIDS Memorial to Dedicate Newly Built Hemophilia Memorial Circle to Honor Lives Lost in Early Days of AIDS Epidemic

SAN FRANCISCO, Sept. 16, 2017 /PRNewswire-USNewswire/ -- Hundreds of hemophilia advocates and survivors came together at the National AIDS Memorial to dedicate the Hemophilia Memorial Circle, a b...

EpiCast Report: Hemophilia Epidemiology Forecast to 2026 [Report Updated: 01072017] Prices from USD $3995

EpiCast Report: Hemophilia Epidemiology Forecast to 2026SummaryHemophilia is an Xlinked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the pro...

New Data to be Presented at ISTH Underscore Bioverativ's Commitment to Advance Hemophilia Care

19 hemophilia-related abstracts will be presented, demonstrating the company's commitment to innovation and addressing serious unmet patient needs in hemophilia Bioverativ Inc. (NASDAQ: BIVV), a g...

New Data to be Presented at ISTH Underscore Bioverativ’s Commitment to Advance Hemophilia Care

Thursday, July 6th 2017 at 11:05am UTC 19 hemophilia-related abstracts will be presented, demonstrating the company’s commitment to innovation and addressing serious unmet patient needs in hemophili...

Shire, MicroHealth to address hemophilia A and B patient needs

Shire, a biotech leader in rare diseases, announced a collaboration with MicroHealth to support a free and secure care monitoring tool for hemophilia A and B patients with inhibitors and their care te...

Roche lines up February decision date for hemophilia prospect

If approved, emicizumab could threaten both Shire and Novo Nordisk's respective hemophilia businesses.

BioMarin, Spark, raising the stakes for hemophilia

The hemophilia market heats up as exciting technology, including gene therapy and RNA interference, are changing the the disease landscape. 

Shire’s Hemophilia Gene Therapy Boosted by Orphan Drug Designation

The FDA has granted orphan drug designation to Shire’s hemophilia A gene therapy, giving it the boost it needs to catch up with others in the field. Shire specializes in the development of drugs...

Drugs and Medications [244 Associated Drugs and Medications listed on BioPortfolio]

Antimicrobial [Safetec of America]

Antimicrobial

A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]

A.B.H.C. INSTANT HAND SANITIZER

Hydrocortisone [Safetec of America, Inc.]

Safetec First Aid 1% Hydrocortisone Cream

Analgesic [Safetec of America, Inc.]

Safetec of America, Inc. PAIN SPRAY

Antiseptic [Safetec of America]

ANTISEPTIC – Benzalkonium chloride liquid Safetec of America

Clinical Trials [533 Associated Clinical Trials listed on BioPortfolio]

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylacti...

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Retrospective, multicenter study in patients with hemophilia B. This study will be placed at 20 to 50 hemophilia treatment centers in North America and the EU, and is designed to estimate...

World Bleeding Disorders Registry

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, retrospective and prospective, observational, World Bleeding Disorders Registry (WBDR). This pil...

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.

Companies [1011 Associated Companies listed on BioPortfolio]

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

Hemophilia Federation of America

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding di...

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education,...

More Information about "Hemophilia Federation of America" on BioPortfolio

We have published hundreds of Hemophilia Federation of America news stories on BioPortfolio along with dozens of Hemophilia Federation of America Clinical Trials and PubMed Articles about Hemophilia Federation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hemophilia Federation of America Companies in our database. You can also find out about relevant Hemophilia Federation of America Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record